IHE vs XBI: holdings overlap, shared companies and scores
As of September 11, 2026, IHE and XBI overlap 0.0% by weight. iShares U.S. Pharmaceuticals ETF (IHE): U.S. pharmaceutical manufacturers. State Street SPDR S&P Biotech ETF (XBI): U.S. biotech industry stocks.
Updated September 11, 2026
How much do IHE and XBI overlap?
As of September 11, 2026, IHE and XBI overlap 0.0% by weight.
0% of IHE is already inside XBI.
0% of XBI is already inside IHE.
IHE holds 56 companies and XBI holds 145; 0 are in both.
Computed by ETF Copilot from both funds' holdings rather than quoted from a data provider, and rebuilt nightly.
How does ETF Copilot score IHE and XBI?
As of September 11, 2026, ETF Copilot scores IHE 6.4 out of 10 and XBI 2.7 out of 10.
They differ most on Growth: IHE 8.5 and XBI 1.6.
The five factor scores behind them are set out below, 0–10 and higher is better, ranked against every US equity ETF we track.
| Factor | IHE | XBI |
|---|---|---|
| Growth | 8.5 | 1.6 |
| Valuation | 4.1 | — |
| Risk | 6.6 | 1.4 |
| Quality | 7.1 | 2.5 |
| Return | 5.1 | 4.7 |
XBI is the cheaper of the two at 0.35% a year
As of September 11, 2026, IHE charges 0.37% a year, yields 1.83% and holds $1.7B in assets across 56 positions.
As of September 11, 2026, XBI charges 0.35% a year, yields 0.15% and holds $11.3B in assets across 145 positions.
| Measure | IHE | XBI |
|---|---|---|
| Expense ratio | 0.37% | 0.35% |
| Dividend yield | 1.83% | 0.15% |
| Assets under management | $1.7B | $11.3B |
| Holdings | 56 | 145 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Where IHE and XBI trade against their own history
IHE trades at 27.3 times earnings, against its own median of 22.5, and is more expensive than 89% of its own 114 monthly readings since 2017.
XBI trades at 23.3 times earnings, against its own median of 17.7, and is more expensive than 79% of its own 114 monthly readings since 2017.
What moved IHE and XBI this week
IHE fell 4.1% in the week to September 11, 2026. The holdings that moved it most were Johnson & Johnson (−4.6%), Eli Lilly (−3.8%) and Royalty Pharma (−8.2%); Axsome Therapeutics (+6.0%) pushed the other way.
XBI fell 5.0% in the week to September 11, 2026. The holdings that moved it most were Dyne Therapeutics (−27.0%), Sellas Life Sciences (−15.7%) and Amgen (−15.0%); Roivant Sciences (+18.6%) pushed the other way.
What do IHE and XBI each hold?
78% of IHE is its ten largest holdings.
16% of XBI is its ten largest holdings.
Compare with similar funds
Cite this
ETF Copilot, “IHE vs XBI holdings overlap and scores”, as of September 11, 2026.
https://etf-copilot.com/compare/ihe-vs-xbi
Register free to unlock IHE vs XBI prices and holdings on ETF Copilot.
Register free →